Dear Editor:
With great interest, we read the paper "Nervous system involvement after infection with COVID-19 and other coronaviruses". The authors speculated that SARS-CoV-2 may cause neurological damages (Wu et al., 2020) . Herein, we provided clinical evidence showing the central nervous system (CNS) involvement for SARS-CoV-2.
A Wuhan male had fever, shortness of breath, and myalgia since Jan 28. On Feb 10, his disease deteriorated and his consciousness suddenly progressed to confusion. Laboratory test indicated low WBC count (3.3×10 9 /L) and lymphopenia (0.8×10 9 /L). Skull computer tomography (CT) was normal ( Figure 1A ), while chest CT showed multiple subpleural ground glass opacities (GGOs) ( Figure 1B This letter describes a COVID-19 case who presented as encephalitis.
To the best of our knowledge, this is an unusual manifestation of COVID-19. Fortunately, encephalitic associate with SARS-CoV-2 is self-limited. Although the definitive diagnosis of viral encephalitis largely depends on virus isolation, this is difficult for COVID-19 because SARS-CoV-2 dissemination is transient and its CSF titer may be extremely low. Consistently, anti-SARS-CoV-2 IgM and IgG were not detectable in the patient's CSF sample (unpublished data). Therefore, physical evaluation of neurological symptom is important to lead a presumptive diagnosis, as we have mentioned in this case. The pathophysiological characteristic of SARS-CoV-2 associated encephalitis is not fully understood. In agreement with Wu and colleagues (Wu et al., 2020) , we speculate that SARS-CoV-2-induced immunologic response may cause inflammatory injury and edema, as a consequence, leading to alterations in consciousness. With the clearance of virus and the use of mannitol, the CSF pressure gradually reduces and the patient's consciousness gradually improves. This might be a rational explanation for the self-limited property of SARS-CoV-2 associated encephalitis. Collectively, this report indicated that CNS may be involved in COVID-19 and highlights the diagnostic and therapeutic approaches to SARS-CoV-2 associated encephalitis. 
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